Actoverco’s Active participation in the 21st International Congress on Cardiovascular Updates in Milad Tower International Conference Hall

Author:
Actoverco
Date:
12 August 2019
34

This congress started on August 20 and will continue until tomorrow, August 23.

This congress started on August 20 and will continue until tomorrow, August 23.

Actoverco currently has 10 active drugs on the market in three lines related to the field of cardiovascular disease, and plans to launch at least two other new drugs in this field by the end of this year.

Related Posts

M_HA18361-2048x1365

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

11 August 2025
nexus23

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

29 July 2025
4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

6 May 2025
روز کارگر-EN-08

Labor Day Tribute from Actoverco

1 May 2025
عید فطر - تلگرام - انگلیسی -04

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

1 April 2025